查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1531866

2024 年弱视全球市场报告

Amblyopia Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年弱视市场规模将稳定成长。 2028年，这一数字将以4.7%的复合年增长率成长至55.9亿美元。预测期内的增长是由数位健康平台的扩展、资源和家长支持的增加、对儿童预防性保健的更多关注、对低视力的认识提高、眼科专科中心和诊所的激增等推动的。这段时期的主要趋势包括诊断技术的进步、新型治疗方法的开发、我们对视觉发育和神经可塑性理解的进步以及新药的引进和核准。

眼科疾病盛行率的增加预计将推动未来低视力市场的成长。眼科疾病包括多种影响眼睛的疾病，从白内障和青光眼等常见疾病到色素性视网膜炎和眼肿瘤等罕见疾病。导致这些疾病增加的因素包括萤幕时间增加、人口老化以及污染等环境因素。尤其是弱视，由于大脑开始忽略较弱眼睛的输入，弱视会加重眼部疾病，如果不及时治疗，可能会导致永久性视力丧失和深度知觉问题。根据美国疾病管制与预防美国(CDC) 的数据，截至 2024 年 1 月，超过 340 万 40 岁以上的美国人失明或视力受损，预计到 2030 年这一数字将增加一倍。因此，眼科疾病盛行率的上升是推动弱视市场成长的驱动因素。

低视力市场的主要企业正在优先考虑数位治疗等治疗技术的进步，以便为患者提供更好的治疗。数位疗法是透过先进软体程式进行的实证干预措施，旨在预防、管理和治疗医学疾病。数位疗法通常由数位平台推动，利用行为和生活方式的改变来改善健康结果，可以独立使用，也可以与传统治疗方法同时使用。例如，美国生物技术公司 Luminopia Inc. 的数位治疗药物「Luminopia One」于 2021 年 9 月获得 FDA核准。这种创新治疗方法利用电视节目来增强被诊断为弱视的儿童的视力，是 FDA核准的第一个针对儿童神经视觉障碍的数位治疗方法，也是第一个治疗方法。次改编电视节目。一项针对 105 名儿童的 3 期临床试验结果显示，与对照组相比，接受治疗的儿童的视力有统计学上的显着改善，平均视力分别为 1.8 线和 0.8 线。此外，62% 的接受治疗的患者有良好的反应，定义为 2 条或更多线的改善，而对照组的比例为 33%。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球低视力市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球低视力市场表现：规模与成长，2018-2023
  • 全球低视力市场预测：规模与成长，2023-2028，2033F

第六章 市场细分

  • 全球低视力市场：依疾病类型分類的表现与预测，2018-2023、2023-2028F、2033F
  • 斜视性弱视
  • 屈光弱视
  • 剥夺性弱视
  • 逆转弱视
  • 全球低视力市场：诊断表现与预测，2018-2023、2023-2028F、2033F
  • 视力检查
  • 照片筛选器
  • 布鲁克纳测试
  • 其他诊断
  • 全球低视力市场：依治疗分类的表现与预测，2018-2023、2023-2028F、2033F
  • 眼罩
  • 阿托品眼药水
  • 眼镜
  • 电玩游戏
  • 其他治疗方法
  • 全球低视力市场：最终使用者的表现与预测，2018-2023、2023-2028F、2033F
  • 医院药房
  • 零售药房
  • 网路药房

第 7 章 区域/国家分析

  • 全球低视力市场：依地区分類的表现与预测，2018-2023、2023-2028F、2033F
  • 全球低视力市场：按国家分類的表现和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 弱视市场：竞争格局
  • 弱视市场：公司简介
    • Novartis AG
    • Takeda Pharmaceutical Company Limited
    • Biocon Limited
    • Astellas Pharma Inc.
    • Alcon Vision LLC

第三十一章 其他重大及创新企业

  • Bausch Health Companies Inc.
  • HOYA Corp.
  • UnityPoint Health
  • Integra LifeSciences
  • Wockhardt Ltd.
  • Welch Allyn
  • Heidelberg Engineering Inc.
  • Orbis International
  • Oculus Optikgerate GmbH
  • Ocutrx Vision Technologies LLC
  • AccuVision
  • Vivid Vision Inc.
  • Fresnel Prism and Lens Co.
  • RevitalVision
  • WOW Vision Therapy

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r18777

Amblyopia, commonly referred to as lazy eye, is a condition affecting the development of vision where one eye does not achieve normal visual acuity, even with corrective eyewear such as glasses or contact lenses. Typically beginning in infancy or early childhood, amblyopia occurs due to a lack of proper coordination between the eye and the brain. As time progresses, the brain starts to favor the eye with better vision, leading to further deterioration of the weaker eye.

There are several types of amblyopia strabismus amblyopia, refractive amblyopia, deprivation amblyopia, and reverse amblyopia. Strabismus amblyopia results from misalignment of the eyes, causing a discrepancy in visual acuity between them. Diagnosis involves visual acuity tests, photo screening, Bruckner tests, and others. Treatment options include the use of eye patches, atropine drops, corrective glasses, and sometimes even therapeutic video games. Amblyopia affects diverse sectors including hospital pharmacies, retail pharmacies, and online pharmacies.

The amblyopia market research report is one of a series of new reports from The Business Research Company that provides amblyopia market statistics, including amblyopia industry global market size, regional shares, competitors with a amblyopia market share, detailed amblyopia market segments, market trends and opportunities, and any further data you may need to thrive in the amblyopia industry. This amblyopia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The amblyopia market size has grown steadily in recent years. It will grow from $4.45 billion in 2023 to $4.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The increase during the historical period can be credited to a rise in ophthalmic disorders, growing consumer demand for affordable eyewear, the prevalence of hyperopia and myopia, a larger elderly population, and increased adoption of telemedicine.

The amblyopia market size is expected to see steady growth in the next few years. It will grow to $5.59 billion in 2028 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to the expansion of digital health platforms, increased availability of resources and parental support, greater focus on preventive healthcare for children, rising awareness about amblyopia, and the proliferation of specialized eye care centers and clinics. Key trends anticipated in this period include advancements in diagnostic technologies, development of novel treatment approaches, progress in understanding visual development and neuroplasticity, as well as the introduction and approval of new pharmaceuticals.

The increasing incidence of ophthalmological diseases is expected to drive growth in the amblyopia market moving forward. Ophthalmological diseases encompass a spectrum of disorders affecting the eyes, ranging from common ailments such as cataracts and glaucoma to rarer conditions such as retinitis pigmentosa and ocular tumors. Factors contributing to the rise in these diseases include increased screen time, aging populations, and environmental factors such as pollution. Amblyopia, in particular, can exacerbate ophthalmological conditions by causing the brain to disregard input from the weaker eye, potentially leading to permanent vision impairment and issues with depth perception if left untreated. According to the Centers for Disease Control and Prevention (CDC), over 3.4 million Americans aged 40 years and older were blind or visually impaired in January 2024, a number expected to double by 2030. Therefore, the escalating prevalence of ophthalmological diseases is a key driver behind the growth of the amblyopia market.

Major companies in the amblyopia market are prioritizing advancements in treatment technologies, such as digital therapeutics, to better cater to patients. Digital therapeutics are evidence-based interventions driven by sophisticated software programs aimed at preventing, managing, or treating medical disorders or diseases. They leverage behavioral and lifestyle changes, often facilitated by digital platforms, to enhance health outcomes and can be used independently or alongside traditional therapies. For instance, Luminopia Inc., a US-based biotechnology company, achieved FDA approval in September 2021 for its digital therapeutic, Luminopia One. This innovative treatment utilizes television shows to enhance vision in children diagnosed with amblyopia, marking the first FDA-approved digital therapeutic for a neuro-visual disorder in children and the first to employ TV shows as a treatment for amblyopia. Results from a phase 3 pivotal trial involving 105 children demonstrated a statistically significant improvement in visual acuity among those receiving treatment compared to controls, with an average improvement of 1.8 lines versus 0.8 lines, respectively. Furthermore, 62% of treated patients exhibited a robust response, defined as a 2-line or greater improvement, compared to 33% in the control group.

In October 2022, Sumitomo Corporation, a Japan-based electrical services company, partnered with Juntendo University to develop a virtual reality (VR) app for amblyopia treatment. This app aims to enhance treatment engagement and efficacy by making therapy more interactive and enjoyable for children. Juntendo University, a prominent private university in Japan, is collaborating to leverage VR technology in optimizing amblyopia treatment protocols.

Major companies operating in the amblyopia market are Novartis AG, Takeda Pharmaceutical Company Limited, Biocon Limited, Astellas Pharma Inc., Alcon Vision LLC, Bausch Health Companies Inc., HOYA Corp., UnityPoint Health, Integra LifeSciences, Wockhardt Ltd., Welch Allyn, Heidelberg Engineering Inc., Orbis International, Oculus Optikgerate GmbH, Ocutrx Vision Technologies LLC, AccuVision, Vivid Vision Inc., Fresnel Prism and Lens Co., RevitalVision, WOW Vision Therapy, Lancastle International Ltd., Novasight, Eyenovia Inc., Adaptica Srl, AmblyoPlay

North America was the largest region in the amblyopia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amblyopia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the amblyopia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The amblyopia market consists of revenues earned by entities by providing services such as screening and diagnosis, vision therapy, patching therapy, and orthoptic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The amblyopia market also includes sales of contact lenses, vision therapy software, lighting products, bangerter filters, and spectacle lenses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Amblyopia Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on amblyopia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for amblyopia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The amblyopia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease Type: Strabismus Amblyopia; Refractive Amblyopia; Deprivation Amblyopia; Reverse Amblyopia
  • 2) By Diagnosis: Visual Acuity Tests; Photo Screening; Bruckner Test; Other Diagnosis
  • 3) By Treatment: Eye Patches; Atropine Drops; Glasses; Video Games; Other Treatments
  • 4) By End User: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
  • Companies Mentioned: Novartis AG; Takeda Pharmaceutical Company Limited; Biocon Limited; Astellas Pharma Inc.; Alcon Vision LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Amblyopia Market Characteristics

3. Amblyopia Market Trends And Strategies

4. Amblyopia Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Amblyopia Market Size and Growth

  • 5.1. Global Amblyopia Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Amblyopia Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Amblyopia Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Amblyopia Market Segmentation

  • 6.1. Global Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Strabismus Amblyopia
  • Refractive Amblyopia
  • Deprivation Amblyopia
  • Reverse Amblyopia
  • 6.2. Global Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Visual Acuity Tests
  • Photo Screening
  • Bruckner Test
  • Other Diagnosis
  • 6.3. Global Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Eye Patches
  • Atropine Drops
  • Glasses
  • Video Games
  • Other Treatments
  • 6.4. Global Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

7. Amblyopia Market Regional And Country Analysis

  • 7.1. Global Amblyopia Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Amblyopia Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Amblyopia Market

  • 8.1. Asia-Pacific Amblyopia Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Amblyopia Market

  • 9.1. China Amblyopia Market Overview
  • 9.2. China Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Amblyopia Market

  • 10.1. India Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Amblyopia Market

  • 11.1. Japan Amblyopia Market Overview
  • 11.2. Japan Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Amblyopia Market

  • 12.1. Australia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Amblyopia Market

  • 13.1. Indonesia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Amblyopia Market

  • 14.1. South Korea Amblyopia Market Overview
  • 14.2. South Korea Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Amblyopia Market

  • 15.1. Western Europe Amblyopia Market Overview
  • 15.2. Western Europe Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Amblyopia Market

  • 16.1. UK Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Amblyopia Market

  • 17.1. Germany Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Amblyopia Market

  • 18.1. France Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Amblyopia Market

  • 19.1. Italy Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Amblyopia Market

  • 20.1. Spain Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Amblyopia Market

  • 21.1. Eastern Europe Amblyopia Market Overview
  • 21.2. Eastern Europe Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Amblyopia Market

  • 22.1. Russia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Amblyopia Market

  • 23.1. North America Amblyopia Market Overview
  • 23.2. North America Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Amblyopia Market

  • 24.1. USA Amblyopia Market Overview
  • 24.2. USA Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Amblyopia Market

  • 25.1. Canada Amblyopia Market Overview
  • 25.2. Canada Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Amblyopia Market

  • 26.1. South America Amblyopia Market Overview
  • 26.2. South America Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Amblyopia Market

  • 27.1. Brazil Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Amblyopia Market

  • 28.1. Middle East Amblyopia Market Overview
  • 28.2. Middle East Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Amblyopia Market

  • 29.1. Africa Amblyopia Market Overview
  • 29.2. Africa Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Amblyopia Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Amblyopia Market Competitive Landscape And Company Profiles

  • 30.1. Amblyopia Market Competitive Landscape
  • 30.2. Amblyopia Market Company Profiles
    • 30.2.1. Novartis AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Takeda Pharmaceutical Company Limited
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Biocon Limited
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Astellas Pharma Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Alcon Vision LLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Amblyopia Market Other Major And Innovative Companies

  • 31.1. Bausch Health Companies Inc.
  • 31.2. HOYA Corp.
  • 31.3. UnityPoint Health
  • 31.4. Integra LifeSciences
  • 31.5. Wockhardt Ltd.
  • 31.6. Welch Allyn
  • 31.7. Heidelberg Engineering Inc.
  • 31.8. Orbis International
  • 31.9. Oculus Optikgerate GmbH
  • 31.10. Ocutrx Vision Technologies LLC
  • 31.11. AccuVision
  • 31.12. Vivid Vision Inc.
  • 31.13. Fresnel Prism and Lens Co.
  • 31.14. RevitalVision
  • 31.15. WOW Vision Therapy

32. Global Amblyopia Market Competitive Benchmarking

33. Global Amblyopia Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Amblyopia Market

35. Amblyopia Market Future Outlook and Potential Analysis

  • 35.1 Amblyopia Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Amblyopia Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Amblyopia Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer